Sep 25, 2026 07:00AM
Sep 25, 2026 07:00AM
Aug 11, 2026 07:00AM
Jun 11, 2026 07:00AM
Jun 11, 2026 07:00AM
May 12, 2026 07:00AM
Mar 25, 2026 07:00AM C4 Therapeutics begins Phase 1b trial of cemsidomide with elranatamab
Mar 25, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 23, 2026 07:00AM
Feb 23, 2026 07:00AM
Jan 14, 2026 07:00AM
Jan 14, 2026 07:00AM
Nov 6, 2025 07:00AM C4 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Sep 20, 2025 11:00AM
Sep 20, 2025 11:00AM
Sep 17, 2025 04:33AM
Sep 4, 2025 07:00AM
Aug 7, 2025 07:00AM
May 7, 2025 07:00AM
Nov 5, 2024 07:05AM PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
Oct 15, 2024 04:03PM
Oct 15, 2024 04:01PM
Sep 13, 2024 10:00AM
Sep 13, 2024 10:00AM
Aug 8, 2023 07:00AM
Jul 5, 2023 07:01AM
Jul 5, 2023 07:00AM C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT8919, an Orally Bioavailable BiDAC™ Degrader Targeting EGFR L858R for Non-Small Cell Lung Cancer
Jun 20, 2023 07:03AM
Jun 20, 2023 07:00AM
May 30, 2023 07:10AM
May 30, 2023 07:00AM
Nov 3, 2022 07:00AM
Nov 3, 2022 07:00AM
Sep 29, 2022 07:01AM C4 Therapeutics Inc. (CCCC) Receives Study May Proceed Letter from FDA to Initiate Phase 1/2 Clinical Trial of CFT1946
Sep 29, 2022 07:00AM
Sep 29, 2022 07:00AM
May 16, 2022 08:00AM
May 16, 2022 08:00AM
May 5, 2022 08:00AM
May 5, 2022 08:00AM
Mar 9, 2022 08:00AM C4 Therapeutics Inc. (CCCC) Granted FDA Orphan Drug Designation for CFT8634
Mar 9, 2022 08:00AM
Mar 9, 2022 08:00AM
Feb 24, 2022 07:00AM
Feb 24, 2022 07:00AM
Jan 10, 2022 07:03AM
Jan 10, 2022 07:00AM
Jan 10, 2022 07:00AM C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio
Nov 10, 2021 04:01PM

334,271 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All